Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 10: 619-626, 1964;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grande, F.
Right arrow Articles by Wada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grande, F.
Right arrow Articles by Wada, S.

Clinical Chemistry, Vol 10, 619-626, Copyright © 1964 by the American Association for Clinical Chemistry

Cholesterol Measurement in Serum and in Plasma

Francisco Grande 1, Donald S. Amatuzio 1, and Shohachi Wada 1

1 Jay Phillips Research Laboratory, Mount Sinai Hospital, and the Departments of Physiological Hygiene and Medicine, University of Minnesota, Minneapolis, Minn.

The effect on the plasma cholesterol concentration of various anticoagulants added to the blood in dry form, as compared with that of serum, has been studied.

The amounts of anticoagulants used, per 5 ml. of blood, were: heparin, 2.5 mg.; oxalate mixture, 12 mg.; tetrasodium EDTA, 5 mg.; sodium oxalate, 12mg.; and ACD mixture, 5.3 mg. citric acid, 15.8 mg. Na citrate, and 17.6 mg. dextrose.

All these anticoagulants caused a decrease in the plasma cholesterol concentration. The mean cholesterol decrease (serum minus plasma) produced by heparin was only 4 mg./100 ml. (S.E., ± 1.24), but this difference was statistically significant. When the heparin was prepared by drying a solution of heparin in 0.9% NaCl a greater difference between serum and plasma was observed.

The cholesterol difference (serum minus plasma) producd by Na oxalate increases with increasing amounts of anticoagulant.

The decrease in plasma cholesterol concentration produced by the anticoagulants can be explained by changes of water distribution between cells and plasma, reflected by changes of hematocrit produced by the anticoagulant.

Submitted on May 16, 1963






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1964 by the American Association for Clinical Chemistry.